Capital Fund Management S.A. Nektar Therapeutics Transaction History

Capital Fund Management S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$3.17 - $6.17 $654,081 - $1.27 Million	206,335 New	206,335 $784,000
Q4 2020 Feb 12, 2021	SELL	$15.77 - $19.03 $364,192 - $439,478	-23,094 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$16.59 - $24.79 $318,395 - $475,769	-19,192 Reduced 45.39%	23,094 $383,000
Q2 2020 Aug 13, 2020	SELL	$16.86 - $23.44 $11.2 Million - $15.6 Million	-664,863 Reduced 94.02%	42,286 $979,000
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $32.5 Million - $47.9 Million	698,705 Added 8274.57%	707,149 $43.1 Million

Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $484,685 - $915,667	8,444 New	8,444 $897,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.